Expression of muscarinic receptors by human macrophages

European Respiratory Journal

Volumn 39, Issue 3, 2012, Pages 698-704

  Koarai, A ^a   Traves, S L ^a   Fenwick, P S ^a   Brown, S M ^a   Chana, K K ^a   Russell, R E K ^b   Nicholson, A G ^a   Barnes, P J ^a   Donnelly, L E ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b KING EDWARD VII HOSPITAL   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Macrophage

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; CARBACHOL; CHOLINE ACETYLTRANSFERASE; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; MESSENGER RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; VESICULAR ACETYLCHOLINE TRANSPORTER;

ACETYLCHOLINE RELEASE; ARTICLE; CELL LINEAGE; CHOLINERGIC SYSTEM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; MONOCYTE MACROPHAGE PRECURSOR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

CARBACHOL; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LEUKOTRIENE B4; MACROPHAGES; MEMBRANE TRANSPORT PROTEINS; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; PIPERIDINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, MUSCARINIC; RNA; SMOKING; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 84860337114     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00136710     Document Type: Article

References (28)

1. Barnes PJ. Macrophages as orchestrators of COPD. J COPD 2004; 1: 50-70.
2. Donnelly LE, Rogers DF. Therapy for chronic obstructive pulmonary disease in the 21st century. Drugs 2003; 63: 1973-1998. (Pubitemid 37229086)
3. Hansel TT, Barnes PJ. Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD. Drugs Today (Barc) 2002; 38: 585-600. (Pubitemid 35190691)
4. Buhling F, Lieder N, Kuhlmann UC, et al. Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir Med 2007; 101: 2386-2394. (Pubitemid 47471396)
5. Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998; 50: 279-290. (Pubitemid 28304029)
6. Lukas RJ, Changeux JP, le Novere N, et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 1999; 51: 397-401. (Pubitemid 29269984)
7. Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: the nonneuronal cholinergic system in humans. Br J Pharmacol 2008; 154: 1558-1571.
8. Gwilt CR, Donnelly LE, Rogers DF. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther 2007; 115: 208-222. (Pubitemid 47042914)
9. Kawashima K, Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 2000; 86: 29-48. (Pubitemid 30173143)
10. KawashimaK, Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci 2003; 74: 675-696. (Pubitemid 37494897)
11. Wessler I, Kilbinger H, Bittinger F, et al. The non-neuronal cholinergic system in humans: Expression, function and pathophysiology. Life Sci 2003; 72: 2055-2061. (Pubitemid 36298947)
12. Sato E, Koyama S, Okubo Y, et al. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol Lung Cell Mol Physiol 1998; 274: L970-L979.
13. Profita M, Giorgi RD, Sala A, et al. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005; 60: 1361-1369. (Pubitemid 41476178)
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S77-S121.
15. Seldon PM, Barnes PJ, Meja K, et al. Suppression of lipopolysaccharide- induced tumor necrosis factor-α generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. Mol Pharmacol 1995; 48: 747-757.
16. Smith SJ, Cieslinski LB, Newton R, et al. Discovery of BRL 50481 (3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene), a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes. Mol Pharmacol 2004; 66: 1679-1689. (Pubitemid 39564796)
17. Smith SJ, Fenwick PS, Nicholson AG, et al. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages. Br J Pharmacol 2006; 149: 393-404. (Pubitemid 44582246)
18. Lim S, Roche N, Oliver BG, et al. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med 2000; 162: 1355-1360.
19. Russell RE, Thorley A, Culpitt SV, et al. Alveolar macrophagemediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol 2002; 283: L867-L873.
20. Culpitt SV, Maziak W, Loukidis S, et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1635-1639.
21. Catley MC, Sukkar MB, Chung KF, et al. Validation of the antiinflammatory properties of small-molecule IκB kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. Mol Pharmacol 2006; 70: 697-705. (Pubitemid 44092330)
22. Neumann S, Razen M, Habermehl P, et al. The non-neuronal cholinergic system in peripheral blood cells: effects of nicotinic and muscarinic receptor antagonists on phagocytosis, respiratory burst and migration. Life Sci 2007; 80: 2361-2364. (Pubitemid 46818263)
23. Hecker A, Lips KS, Pfeil U, et al. Peripheral choline acetyltransferase is expressed by monocytes and upregulated during renal allograft rejection in rats. J Mol Neurosci 2006; 30: 23-24. (Pubitemid 46035304)
24. Wessler IK, Kirkpatrick CJ. The non-neuronal cholinergic system: an emerging drug target in the airways. Pulm Pharmacol Ther 2001; 14: 423-434. (Pubitemid 34081694)
25. Hellstrom-Lindahl E, Nordberg A. Muscarinic receptor subtypes in subpopulations of human blood mononuclear cells as analyzed by RT-PCR technique. J Neuroimmunol 1996; 68: 139-144. (Pubitemid 26279256)
26. Birrell MA, Wong S, Catley MC, et al. Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol 2008; 214: 27-37. (Pubitemid 350220056)
27. Finney-Hayward TK, Bahra P, Li S, et al. Leukotriene B4 release by human lung macrophages via receptor-not voltage-operated Ca2+ channels. Eur Respir J 2009; 33: 1105-1112.
28. Bateman ED, Rennard S, Barnes PJ, et al. Alternative mechanisms for tiotropium. Pulm Pharmacol Ther 2009; 22: 533-542.